Loading insider details...
Beta
Latest Form 4 (Oct 2, 2026): Grant/Award of 1,352 AVTX shares, $16.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Avalo Therapeutics, Inc. (AVTX) | Grant/Award | 1,352 | $16.6K |
| Aug 3, 2026 | Apnimed, Inc. (APMD) | Disposition to Issuer | 74,128 | n/a |
| Jul 2, 2026 | Avalo Therapeutics, Inc. (AVTX) | Grant/Award | 1,105 | $16.6K |
| Jun 4, 2026 | Avalo Therapeutics, Inc. (AVTX) | Grant/Award | 20,100 | n/a |
| Apr 1, 2026 | Avalo Therapeutics, Inc. (AVTX) | Grant/Award | 1,370 | $16.6K |
| Jan 5, 2026 | Avalo Therapeutics, Inc. (AVTX) | Grant/Award | 848 | $12.5K |
| Oct 2, 2025 | Avalo Therapeutics, Inc. (AVTX) | Grant/Award | 40,200 | n/a |
| Oct 29, 2024 | Longboard Pharmaceuticals, Inc. (LBPH) | Grant/Award | 22,000 | n/a |
| Aug 13, 2024 | Longboard Pharmaceuticals, Inc. (LBPH) | Exercise/Conversion | 80,265 | $250.7K |
| Feb 9, 2024 | Longboard Pharmaceuticals, Inc. (LBPH) | Grant/Award | 332,134 | n/a |